These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 3035660)

  • 1. Efficacy of a bivalent vaccine against Marek's disease.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Mar; 42(2):145-9. PubMed ID: 3035660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field trials with a bivalent vaccine (HVT and SB-1) against Marek's disease.
    Calnek BW; Schat KA; Peckham MC; Fabricant J
    Avian Dis; 1983; 27(3):844-9. PubMed ID: 6314982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the pathology of Marek's disease following challenge in chicks vaccinated with three different vaccines.
    Pruthi AK; Gupta RK; Sadana JR
    J Comp Pathol; 1989 Oct; 101(3):295-305. PubMed ID: 2555401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials with Marek's disease vaccines prepared from a turkey herpes virus and an attenuated Marek's disease virus.
    Blaxland JD; Macleod AJ; Hall T
    Vet Rec; 1975 Jul; 97(3):50-2. PubMed ID: 168681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC; Firth GA; Tannock GA
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
    Eidson CS; Page RK; Kleven SH
    Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
    [No Abstract]   [Full Text] [Related]  

  • 12. Humoral immune responses to inactivated oil-emulsified Marek's disease vaccine.
    Lee LF; Witter RL
    Avian Dis; 1991; 35(3):452-9. PubMed ID: 1659363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy.
    Witter RL
    Avian Dis; 1991; 35(4):877-91. PubMed ID: 1664721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.
    Witter RL; Sharma JM; Lee LF; Opitz HM; Henry CW
    Avian Dis; 1984; 28(1):44-60. PubMed ID: 6326743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marek's disease--the disease and its prevention by vaccination.
    Biggs PM
    Br J Cancer Suppl; 1975 Mar; 2():152-5. PubMed ID: 170953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acyclovir on the replication of turkey herpesvirus and Marek's disease virus.
    Samorek-Salamonowicz E; Cakala A; Wijaszka T
    Res Vet Sci; 1987 May; 42(3):334-8. PubMed ID: 3039621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acid alpha naphthyl acetate esterase reacting lymphocytes in the peripheral blood of chickens challenged with Marek's disease after vaccination with three different vaccines.
    Pruthi AK; Gupta RK; Sadana JR
    Res Vet Sci; 1987 Jul; 43(1):92-6. PubMed ID: 3628992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenicity of a Marek's disease virus for chickens vaccinated with graded doses of herpesvirus of turkeys.
    Cauchy L; Coudert F; Dambrine G
    Avian Dis; 1979; 23(4):821-30. PubMed ID: 546406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.